scPharmaceuticals Cash from Financing (TTM) Analysis

scPharmaceuticals Inc (SCPH)

4.66 +0.10 (+2.19%) USD | NASDAQ | May 02, 16:00

4.66 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	14.85M
September 30, 2023	98.98M
June 30, 2023	96.44M
March 31, 2023	93.41M
December 31, 2022	77.23M
September 30, 2022	-9.83M
June 30, 2022	-7.353M
March 31, 2022	-4.937M
December 31, 2021	-2.53M
September 30, 2021	-0.052M
June 30, 2021	-0.134M
March 31, 2021	49.82M
December 31, 2020	60.35M

Date	Value
September 30, 2020	64.22M
June 30, 2020	73.98M
March 31, 2020	24.03M
December 31, 2019	13.59M
September 30, 2019	9.63M
June 30, 2019	-0.047M
March 31, 2019	-0.046M
December 31, 2018	-0.008M
September 30, 2018	92.46M
June 30, 2018	92.46M
March 31, 2018	102.14M
December 31, 2017	102.07M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-9.83M

Minimum

Sep 2022

98.98M

Maximum

Sep 2023

34.30M

Average

14.85M

Median

Dec 2023

Cash from Financing (TTM) Benchmarks